Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | PTPRC | P08575 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29177616 | 0.82 | MLYCD (0.39) | RECQLGAATDP1MAOAMAOB | |
| SCHEMBL2842540 | 0.81 | MEN1 (0.43) | RECQLPTPRCGAACA12CA2 | |
| SCHEMBL4814182 | 0.81 | RECQL (0.42) | RECQLPTPRCGAACA12CA2 | |
| SCHEMBL4814188 | 0.81 | RECQL (0.42) | RECQLPTPRCGAACA12CA2 | |
| SCHEMBL22345261 | 0.80 | RECQL (0.61) | RECQLGAAL3MBTL1TET2 | |
| SCHEMBL19011660 | 0.79 | MEN1 (0.35) | MAOAMAOBMEN1KMT2A | |
| SCHEMBL23299718 | 0.79 | RECQL (0.41) | RECQLPTPRCGAACA12CA2 | |
| SCHEMBL8558174 | 0.79 | RECQL (0.50) | RECQLPTPRCGAACA12CA2 | |
| SCHEMBL20829083 | 0.79 | RECQL (0.41) | RECQLPTPRCGAACA12CA2 | |
| SCHEMBL16761943 | 0.79 | RECQL (0.41) | RECQLPTPRCGAACA12CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114931651-B | Targeting-drug based on antibody IgG1-Fc structural domain, and preparation method and application thereof | 武汉大学 | 2025-03-04 | — | — | CN | disclosed |
| CN-114931651-A | Targeting-drug based on IgG1-Fc structural domain of antibody, and preparation method and application thereof | 武汉大学 | 2022-08-23 | — | — | CN | disclosed |
| WO-2008098056-A2 | HIGH RELAXIVITY CHELATES | EPIX PHARMACEUTICALS, INC. (US) | 2008-08-14 | — | — | WO | disclosed |
| US-20060275217-A1 | Chemical exchange saturation transfer contrast agents | EPIX PHARMACEUTICALS, INC. | 2006-12-07 | — | — | US | disclosed |
| WO-2006121889-A2 | CHEMICAL EXCHANGE SATURATION TRANSFER CONTRAST AGENTS | EPIX PHARMACEUTICALS, INC. (US) | 2006-11-16 | — | — | WO | disclosed |
| EP-0946525-B1 | METHOD FOR PRODUCING METAL COMPLEX CARBOXYLIC ACID AMIDES | SCHERING AG (DE) | 2004-04-07 | — | — | EP | disclosed |
| EP-0946526-B1 | MACROCYCLIC METAL COMPLEX CARBOXYLIC ACIDS, USE AND METHOD FOR THE PRODUCTION THEREOF | SCHERING AG (DE) | 2003-10-29 | — | — | EP | disclosed |
| US-6045776-A | Process for the production of metal-complex carboxylic acid amides | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-04-04 | — | — | US | disclosed |
| EP-0946525-A1 | METHOD FOR PRODUCING METAL COMPLEX CARBOXYLIC ACID AMIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-10-06 | — | — | EP | disclosed |
| EP-0946526-A1 | MACROCYCLIC METAL COMPLEX CARBOXYLIC ACIDS, USE AND METHOD FOR THE PRODUCTION THEREOF | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-10-06 | — | — | EP | disclosed |
| US-5919433-A | NUCLEAR MAGNETIC RESONANCE | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-07-06 | — | — | US | disclosed |
| WO-1998024775-A1 | METHOD FOR PRODUCING METAL COMPLEX CARBOXYLIC ACID AMIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-06-11 | — | — | WO | disclosed |
| WO-1998024774-A1 | MACROCYCLIC METAL COMPLEX CARBOXYLIC ACIDS, USE AND METHOD FOR THE PRODUCTION THEREOF | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060275217-A1 | Chemical exchange saturation transfer contrast agents | SLC39A11, SLC30A7, SLC39A7 | RECQL 4502/4885PTPRC 4544/4885GAA 1096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.